Certara Inc.

14.54
0.39 (2.76%)
At close: Apr 21, 2025, 3:59 PM
14.59
0.39%
Pre-market: Apr 22, 2025, 08:11 AM EDT

Company Description

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access.

It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development.

The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market.

Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access.

Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform.

The company serves biopharmaceutical companies, and academic and government institutions.

It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China.

Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Certara Inc.
Certara Inc. logo
Country United States
IPO Date Dec 11, 2020
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 1,487
CEO Dr. William F. Feehery Ph.D.

Contact Details

Address:
100 Overlook Center
Princeton, New Jersey
United States
Website https://www.certara.com

Stock Details

Ticker Symbol CERT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001827090
CUSIP Number 15687V109
ISIN Number US15687V1098
Employer ID 00-0000000
SIC Code 7372

Key Executives

Name Position
Dr. William F. Feehery Ph.D. Chief Executive Officer & Director
John E. Gallagher III SVice President, Principal Accounting Officer & Chief Financial Officer
Sheila Rocchio MBA Chief Marketing Officer
Daniel D. Corcoran Senior Vice President & General Counsel
Dr. David Mitchell Ph.D. Senior Vice President of Strategic Engagement
Dr. Frederic Yves Bois Ph.D., Pharm.D. Senior Scientific Advisor, Head of Mechanistic Modeling & Member of Simcyp Advisory Board
Dr. Robert P. Aspbury Ph.D. President of Certara Scientific Software
Leif E. Pedersen President & Chief Commercial Officer
Ron DiSantis Senior Vice President of Corporate Development
Rona Anhalt Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Apr 14, 2025 SCHEDULE 13D/A [Amend] Filing
Apr 14, 2025 8-K Current Report
Apr 08, 2025 ARS Filing
Apr 08, 2025 DEFA14A Filing
Apr 08, 2025 DEF 14A Filing
Apr 03, 2025 4 Filing
Apr 03, 2025 4 Filing
Apr 03, 2025 4 Filing
Apr 03, 2025 4 Filing
Mar 28, 2025 D Filing